brain tumors
Conditions
Interventions
Control group:none
Sponsors
Xinhua Hospital, Shanghai Jiao Tong University
Eligibility
Sex/Gender
All
Age
3 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Aged >=3 years, no gender limit; 2. Patients with confirmed primary medulloblastoma (with definite pathological diagnosis) and primary brain stem tumor (with enhanced MR diagnosis); 3. KPS score >=50; 4. Expected survival time >=2 months; 5. Patients with medulloblastoma who had received surgical treatment but no previous radiation or chemotherapy; The diagnosis of brain stem tumor was clear and no previous radiotherapy or chemotherapy was received; 6. Patients voluntarily participate in this study, and patients or legal guardians sign informed consent with the consent of patients, with good compliance and follow-up.
Exclusion criteria
Exclusion criteria: 1. Recurrent patients; 2. Prior radiotherapy and chemotherapy; 3. Previous or concurrent malignancy; 4. According to the investigator's judgment, patients with other concomitant diseases that seriously endanger patients' safety or affect patients' ability to complete the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MRI;Metabolite; | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement of symptoms;Radiotherapy-related side effects; | — |
Countries
China
Contacts
Public ContactJiang Mawei
Xinhua Hospital, Shanghai Jiao Tong University
Outcome results
None listed